Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Chatain

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 6, 2025
Designing and modeling nanomedicines towards image-guided drug delivery in hematological malignanciesShiva Khorshid, Julian Baumeister, Federica De Lorenzi, et al.
Leukemia|July 21, 2020
Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemiaOliver Parting, Samantha Langer, Maja Kim Kuepper, et al.
Cell Communication and Signaling : CCS|June 24, 2026
Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasmsPatrick Weiand, Nicolas Chatain, Marcelo A Szymanski de Toledo, et al.
Frontiers in Cell and Developmental Biology|August 9, 2021
Human DC3 Antigen Presenting Dendritic Cells From Induced Pluripotent Stem CellsTaiki Satoh, Marcelo A S Toledo, Janik Boehnke, et al.
Leukemia|March 8, 2019
Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signalingMaja Kim Kuepper, Marlena Bütow, Oliver Herrmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Intercellular trafficking of the nuclear oncoprotein DEKAnjan K Saha, Ferdinand Kappes, Amruta Mundade, et al.
International Journal of Molecular Sciences|March 29, 2023
KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional ProfileMarcelo A S de Toledo, Xuhuang Fu, Tiago Maié, et al.
Frontiers in Pharmacology|July 20, 2023
Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patientsHenrike Jacobi, Margherita Vieri, Marlena Bütow, et al.
Annals of Hematology|August 14, 2021
Early and late stage MPN patients show distinct gene expression profiles in CD34<sup>+</sup> cellsJulian Baumeister, Tiago Maié, Nicolas Chatain, et al.
Leukemia|November 16, 2019
Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasmsJulian Baumeister, Nicolas Chatain, Annika Hubrich, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 6, 2025
Designing and modeling nanomedicines towards image-guided drug delivery in hematological malignanciesShiva Khorshid, Julian Baumeister, Federica De Lorenzi, et al.
Leukemia|July 21, 2020
Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemiaOliver Parting, Samantha Langer, Maja Kim Kuepper, et al.
Cell Communication and Signaling : CCS|June 24, 2026
Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasmsPatrick Weiand, Nicolas Chatain, Marcelo A Szymanski de Toledo, et al.
Frontiers in Cell and Developmental Biology|August 9, 2021
Human DC3 Antigen Presenting Dendritic Cells From Induced Pluripotent Stem CellsTaiki Satoh, Marcelo A S Toledo, Janik Boehnke, et al.
Leukemia|March 8, 2019
Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signalingMaja Kim Kuepper, Marlena Bütow, Oliver Herrmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Intercellular trafficking of the nuclear oncoprotein DEKAnjan K Saha, Ferdinand Kappes, Amruta Mundade, et al.
International Journal of Molecular Sciences|March 29, 2023
KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional ProfileMarcelo A S de Toledo, Xuhuang Fu, Tiago Maié, et al.
Frontiers in Pharmacology|July 20, 2023
Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patientsHenrike Jacobi, Margherita Vieri, Marlena Bütow, et al.
Annals of Hematology|August 14, 2021
Early and late stage MPN patients show distinct gene expression profiles in CD34<sup>+</sup> cellsJulian Baumeister, Tiago Maié, Nicolas Chatain, et al.
Leukemia|November 16, 2019
Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasmsJulian Baumeister, Nicolas Chatain, Annika Hubrich, et al.
Pageof 5